Clinical trials recruiting for mCRPC (Metastatic Castration-resistant Prostate Cancer)
12
Recruiting trials
26
US states with sites
6
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 6 |
| Florida | 4 |
| Michigan | 4 |
| Nebraska | 4 |
| Maryland | 3 |
| Massachusetts | 3 |
| Minnesota | 3 |
| New York | 3 |
| South Carolina | 3 |
| Texas | 3 |
| Illinois | 2 |
| North Carolina | 2 |
Top cities
Omaha, Nebraska 4Boston, Massachusetts 3Miami, Florida 3Myrtle Beach, South Carolina 3New York, New York 3Baltimore, Maryland 2Chicago, Illinois 2Columbus, Ohio 2Detroit, Michigan 2Durham, North Carolina 2
Self-screener
Recruiting trials
- A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- A Study of MHB048C in Patients With Advanced Solid Tumors
- A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer Heterogeneity
- Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
- Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC
- Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer
Related conditions
Trials recruiting for mCRPC (Metastatic Castration-resistant Prostate Cancer) often also study these conditions. Each links to its own recruiting-trial list.
Prostate cancer 1234mCRPC 8Prostatic Neoplasms, Castration-Resistant 13Prostate Cancer (Adenocarcinoma) 43Metastatic Castration Resistant Prostate Cancer 67Prostatic Neoplasms 36Non-small cell lung cancer 507Nonsmall Cell Lung Cancer 7Neoplasms Prostate 6Metastatic Castration-Resistant Prostate Cancer Patients 4
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for mCRPC (Metastatic Castration-resistant Prostate Cancer) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.